Atlas Venture Associates Opportunity I, L.P. - Insider Non-Derivative Transactions at Xilio Therapeutics, Inc. (XLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 12, 2024, Atlas Venture Associates Opportunity I, L.P.'s relationship to Xilio Therapeutics, Inc. (XLO) is TenPercentOwner, and currently has 2,020,296 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other XLO insiders.
Data Source: SEC.
Atlas Venture Associates Opportunity I, L.P. - Insider Non-Derivative Transactions of XLO Common Stock
Atlas Venture Associates Opportunity I, L.P. - Insider Non-Derivative Transactions at XLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 13, 2024 | Sell -- (Common Stock) | 560 | 0.83 | 734813 |
| Jan 13, 2024 | Sell -- (Common Stock) | 1540 | 0.83 | 2020296 |
| Jan 12, 2024 | Sell -- (Common Stock) | 569 | 0.87 | 735373 |
| Jan 12, 2024 | Sell -- (Common Stock) | 1566 | 0.87 | 2021836 |